Reprogramming Protein Therapeutics to Restore Immune Balance in Animal Models
4:45 pm - Wednesday 1st April 2026
- Advancing a novel protein platform toward safer, precision treatments for inflammatory disease
- Leveraging embedded epitope random copolymer proteins to reprogram immunity without suppressing healthy responses
- Demonstrating disease-specific efficacy in multiple animal models of Crohn’s disease, uveitis, and multiple sclerosis
